Signal #165884 · SEC 8-K

$QNRX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $QNRX filing catalyst

Why did $QNRX trigger an AI stock catalyst alert?

$QNRX triggered a Stock Catalyst AI alert on 2026-11-06 22:18:56 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Quoin Pharmaceuticals Reports Positive Phase 2/3 Interim Data and Up to $50M Financing. Key points: - QRX003 achieved statistical significance on primary and secondary endpoints in ongoing Phase 2/3 study - Announced private placement financing of up to $50.0M with institutional investors - FDA cleared IND for Peeling Skin Syndrome (PSS); reported cash position of $10.1M

How did $QNRX stock react after the SEC filing?

After the SEC 8-K for $QNRX, observed market reaction: T0 price $3.65. Past moves do not guarantee future results.

Where can I get real-time $QNRX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $QNRX via Telegram and the VIP Web Terminal from €10/month.

$QNRX

$QNRX – Quoin Pharmaceuticals Reports Positive Phase 2/3 Interim Data and Up to $50M Financing

Quoin Pharmaceuticals Ltd.

2026-11-06 22:18:56 UTC · SEC 8-K · All $QNRX

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

QRX003 achieved statistical significance on primary and secondary endpoints in ongoing Phase 2/3 study
Announced private placement financing of up to $50.0M with institutional investors
FDA cleared IND for Peeling Skin Syndrome (PSS); reported cash position of $10.1M

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →